Close Menu

NEW YORK –  As second quarter financial results began to trickle in, July provided mixed returns for the stocks of diagnostics companies, and the 360Dx Index was essentially flat month over month.

Of the 27 companies in the index, 12 firms' share prices retreated last month,  14 companies' stocks increased, and Natera's stock price was flat month over month.

The index trailed the Dow Jones Industrial Average, which inched up 1 percent month over month, and the Nasdaq, which grew 3 percent, but it beat the Nasdaq Biotech Index, which was down 2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.